We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,750 results
  1. Molecular hydrogen attenuates sepsis-induced cardiomyopathy in mice by promoting autophagy

    Background

    Approximately 40 to 60% of patients with sepsis develop sepsis-induced cardiomyopathy (SIC), which is associated with a substantial...

    Yan Cui, Yingning Li, ... Keliang **e in BMC Anesthesiology
    Article Open access 23 February 2024
  2. Therapeutic Strategies Targeting Mitochondrial Dysfunction in Sepsis-induced Cardiomyopathy

    Sepsis is an increasingly worldwide problem; it is currently regarded as a complex life-threatening dysfunction of one or more organs as a result of...

    Oluwabukunmi Modupe Salami, Olive Habimana, ... Guang-Hui Yi in Cardiovascular Drugs and Therapy
    Article 15 June 2022
  3. Association of sepsis-induced cardiomyopathy and mortality: a systematic review and meta-analysis

    Background

    The implication of sepsis-induced cardiomyopathy (SIC) to prognosis is controversial, and its association with mortality at different...

    Yu-Min Lin, Mei-Chuan Lee, ... Chia-Te Liao in Annals of Intensive Care
    Article Open access 13 December 2022
  4. Pathophysiology of sepsis-induced cardiomyopathy

    Sepsis is the life-threatening organ dysfunction caused by a dysregulated host response to infection and is the leading cause of death in intensive...

    Steven M. Hollenberg, Mervyn Singer in Nature Reviews Cardiology
    Article 20 January 2021
  5. Feasibility and discriminatory value of tissue motion annular displacement in sepsis-induced cardiomyopathy: a single-center retrospective observational study

    Background

    There is no formal diagnostic criterion for sepsis-induced cardiomyopathy (SICM), but left ventricular ejection fraction (LVEF) < 50% was...

    Jieqiong Song, Yao Yao, ... Ming Zhong in Critical Care
    Article Open access 18 July 2022
  6. Pseudo-Wellens syndrome from sepsis-induced cardiomyopathy: a case report and review of the literature

    Background

    Pseudo-Wellens syndrome is a rare entity characterized by the presence of electrocardiogram (ECG) changes of Wellens syndrome but without...

    Teressa Reanne Ju, Ilhwan Yeo, ... Reema Bhatt in Journal of Medical Case Reports
    Article Open access 06 April 2021
  7. Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction

    Background and Aims

    The triggering factors of sepsis-induced myocardial dysfunction (SIMD) are poorly understood and are not addressed by current...

    Gabriel Jakobsson, Praveen Papareddy, ... Alexandru Schiopu in Critical Care
    Article Open access 29 September 2023
  8. MiR-31-5p alleviates septic cardiomyopathy by targeting BAP1 to inhibit SLC7A11 deubiquitination and ferroptosis

    Septic cardiomyopathy is one of the most severe and common complications in patients with sepsis and poses a great threat to their prognosis....

    Yafeng Liu, Niandan Hu, ... Wenqiang Li in BMC Cardiovascular Disorders
    Article Open access 30 May 2024
  9. The clinical effectiveness of sivelestat in treating sepsis patients with both acute respiratory distress syndrome and septic cardiomyopathy

    Background

    We aimed to assess the efficacy of the neutrophil elastase inhibitor, sivelestat, in the treatment of sepsis-induced acute respiratory...

    Hui Lv, Lang**g Huang, ... **aoke Shang in Journal of Cardiothoracic Surgery
    Article Open access 27 June 2024
  10. **nyang tablet ameliorates sepsis-induced myocardial dysfunction by regulating Beclin-1 to mediate macrophage autophagy and M2 polarization through LncSICRNT1 targeting E3 ubiquitin ligase TRAF6

    Objective

    **nyang Tablet (XYT) has emerged as a potential intervention to counter sepsis-induced myocardial dysfunction (SMID) by influencing...

    Yuanyuan Luo, Yuanmei Li, ... Zhongqi Yang in Chinese Medicine
    Article Open access 02 November 2023
  11. Predictors and nomogram of in-hospital mortality in sepsis-induced myocardial injury: a retrospective cohort study

    Background

    Sepsis-induced myocardial injury (SIMI) is a common organ dysfunction and is associated with higher mortality in patients with sepsis. We...

    Kai-Zhi Xu, ** Xu, ... Fang Han in BMC Anesthesiology
    Article Open access 07 July 2023
  12. Therapeutic Approaches Targeting Ferroptosis in Cardiomyopathy

    The term cardiomyopathy refers to a group of heart diseases that cause severe heart failure over time. Cardiomyopathies have been proven to be...

    Yanqian Ruan, Ling Zhang, ... Keyang Zhu in Cardiovascular Drugs and Therapy
    Article 06 November 2023
  13. Cytosolic mtDNA–cGAS–STING axis contributes to sepsis-induced acute kidney injury via activating the NLRP3 inflammasome

    Background

    NLRP3 inflammasome activation is significantly associated with sepsis-induced acute kidney injury (S-AKI). Cytosolic DNA derived from...

    ** Luo, Yang Zhao, ... **gchen Liu in Clinical and Experimental Nephrology
    Article 19 January 2024
  14. Sepsis-Induced Cardiomyopathy: a Comprehensive Review

    Purpose of Review

    To briefly review epidemiology and pathophysiology of SICM and provide a more extensive review of the data on diagnostic and...

    Michael L’Heureux, Michael Sternberg, ... Markos G. Kashiouris in Current Cardiology Reports
    Article 06 May 2020
  15. miR-22 alleviates sepsis-induced acute kidney injury via targeting the HMGB1/TLR4/NF-κB signaling pathway

    Background

    Acute kidney injury (AKI) is a severe complication of sepsis, and is strongly correlated with MicroRNAs (miRNAs). However, the mechanism of...

    Jie Zhang, Qi Chen, ... Huibin Pan in International Urology and Nephrology
    Article Open access 12 August 2022
  16. Protective Role of lncRNA TTN-AS1 in Sepsis-Induced Myocardial Injury Via miR-29a/E2F2 Axis

    Objective

    Approximately 50% of patients with sepsis encounter myocardial injury. The mortality of septic patients with cardiac dysfunction (approx....

    **nghua Pei, Yanhong Wu, ... Wu Lu in Cardiovascular Drugs and Therapy
    Article 14 September 2021
  17. Unusual cerebral intraventricular hemorrhage and cardiomyopathy related to congenital cytomegalovirus from non-primary maternal infection: a case report

    Background

    Congenital cytomegalovirus (cCMV) infection, resulting from non-primary maternal infection or reactivation during pregnancy, can cause...

    Victoria Malherbe, Stefanie Celen, ... Fiammetta Piersigilli in Italian Journal of Pediatrics
    Article Open access 16 April 2024
  18. Irisin attenuates type 1 diabetic cardiomyopathy by anti-ferroptosis via SIRT1-mediated deacetylation of p53

    Background

    Diabetic cardiomyopathy (DCM) is a serious complication in patients with type 1 diabetes mellitus (T1DM), which still lacks adequate...

    Yuan-juan Tang, Zhen Zhang, ... **-juan Fu in Cardiovascular Diabetology
    Article Open access 02 April 2024
  19. Moderate exercise-induced dynamics on key sepsis-associated signaling pathways in the liver

    Background

    There is a clear relationship between quantitative measures of fitness (e.g., VO 2 max) and outcomes after surgical procedures. Whether or...

    Hari Prasad Osuru, Keita Ikeda, ... Robert H. Thiele in Critical Care
    Article Open access 05 July 2023
Did you find what you were looking for? Share feedback.